行情

OGEN

OGEN

ORAGENICS
AMEX
0.2320
-0.0079
-3.29%
盘前: 0.2500 +0.018 +7.76% 07:18 10/05 EDT
开盘
0.2395
昨收
0.2399
最高
0.2400
最低
0.2300
成交量
200
成交额
--
52周最高
0.7699
52周最低
0.2184
市值
2,700.36万
市盈率(TTM)
-1.6122
分时
5日
1月
3月
1年
5年
Oragenics(OGEN.US)盘前涨超60% 与加拿大合作研发新冠疫苗
Oragenics(OGEN.US)盘前涨超60% 与加拿大合作研发新冠疫苗
智通财经 · 2021/07/27 12:54
OGEN 简况
Oragenics, Inc. is a development-stage company that is focused on fighting infectious diseases, including coronaviruses and multidrug-resistant organisms. The Company's lead product, NT-CoV2-1, is an intranasal immunization vaccine candidate to prevent COVID-19 and variants of the SARS-CoV-2 virus. Its other product candidates include Terra CoV-2 and Antibiotics. Terra CoV-2 is an intramuscular vaccine candidate (plasmid + adjuvant) to provide long-lasting immunity against SARS-CoV-2. Antibiotics is a semi-synthetic analogs of MU1140, which is a member of lantibiotic class of antibiotics. The Company, through its wholly owned subsidiary, Noachis Terra, Inc. (Noachis Terra), is engaged in the research and development of its Terra CoV-2 and NT-CoV2-1 vaccine product candidates. It is also developing semi-synthetic lantibiotic analogs that may be effective against systemic Gram-positive multidrug infections, and analogs that may be effective in treating Gram negative infections.

微牛提供Oragenics Inc(AMEX-OGEN)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的OGEN股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易OGEN股票基本功能。